CA
BSX icon

CSM Advisors’s Boston Scientific BSX Stock Holding History

CSM Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Sell
59,629
-9
-0% -$489 0.05% 299
2026
Q1 		$3.74M Buy
+59,638
New +$4.77M 0.09% 249

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CSM Advisors's BSX Position: Q2 2026 in Review

CSM Advisors reduced its Boston Scientific (BSX) stake by 0.02% in Q2 2026, selling an estimated $489 and leaving 59,629 shares worth $2.54M. The position accounts for 0.05% of the portfolio, ranked #299.

CSM Advisors first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.74M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CSM Advisors held 59,629 shares of Boston Scientific worth $2.54M as of Q2 2026.
  • CSM Advisors sold 9 Boston Scientific shares in Q2 2026, an estimated $489.
  • Boston Scientific made up 0.05% of CSM Advisors's portfolio in Q2 2026, its #299 holding.
  • CSM Advisors first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • CSM Advisors's Boston Scientific position peaked at $3.74M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.